4
Changes in Ownership
EXOZYMES INC. Filed Acc 0001493152-26-041290
Chief Executive Officer bought 855 shares at an average $7.49 ($6,405)
- Chief Executive Officer acquired 8,841 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heltzen Michael Chief Executive Officer | 2026-08-26 | Purchase | +4 | $7.58 | $30 | 14,708 | D: show line 1 in the form |
| Heltzen Michael Chief Executive Officer | 2026-08-26 | Purchase | +251 | $7.35 | $1,845 | 14,704 | D: show line 2 in the form |
| Heltzen Michael Chief Executive Officer | 2026-08-26 | Purchase | +250 | $7.60 | $1,900 | 14,453 | D: show line 3 in the form |
| Heltzen Michael Chief Executive Officer | 2026-08-25 | Purchase | +250 | $7.52 | $1,880 | 14,203 | D: show line 4 in the form |
| Heltzen Michael Chief Executive Officer | 2026-08-25 | Purchase | +100 | $7.50 | $750 | 13,953 | D: show line 5 in the form |
| Heltzen Michael Chief Executive Officer | 2026-08-19 | Grant or award | +8,841 | $6.40 | $56,582 | 13,853 | D: show line 6 in the form |
| Open-market purchases · 855 sh · avg $7.49 · $6,405 | |||||||
Loading xslF345X06/ownership.xml…